Spironolactone for Pulmonary Arterial Hypertension (opens ClinicalTrials.gov)
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Enrolment
- 70
- Started
- 2014-01-10
- Last update
- 2026-11-03
Conditions: Pulmonary Arterial Hypertension
Interventions: Spironolactone, Placebo